Tetrahydrobenzothiophene compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9284295
APP PUB NO 20140329802A1
SERIAL NO

14229146

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The purpose is to provide a compound which has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASTELLAS PHARMA INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hachiya, Shunichiro Chuo-ku, JP 14 80
Imamura, Yoshimasa Chuo-ku, JP 15 205
Kaga, Daisuke Chuo-ku, JP 10 83
Kato, Koji Chuo-ku, JP 221 2108
Miura, Masanori Chuo-ku, JP 44 187
Moritomo, Hiroyuki Chuo-ku, JP 35 780
Sato, Ippei Chuo-ku, JP 19 83
Terada, Yoh Chuo-ku, JP 9 72
Terai, Kazuhiro Chuo-ku, JP 9 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00